Validation Center

NextELN publishes evidence separately from product claims. Every scientific tool is tracked through a versioned validation record: intended use, dataset, split policy, baseline, metrics, calibration, limitations, model and code versions, and prospective results.

Current program

Tool	Status	Required evidence before promotion
Protein structure & confidence viewer	Beta	Held-out structure agreement, confidence/failure analysis, runtime and coverage.
Antigenic-peptide prioritizer	Beta	Retrospective successful/failed peptides plus prospective comparison to baseline.
Nanobody Variant Prioritizer	Research preview	Prospective expression, monomer, stability, specificity and affinity case study.
mRNA vaccine candidate design	Research preview	Expert-reviewed preclinical workflow; no efficacy or safety claim.
Bispecific development	Literature review / roadmap	Structured development workspace before predictive design claims.

Promotion rules

A research preview cannot become Beta without a locked benchmark, documented limitations, acceptance criteria, and human scientific approval. Beta cannot become Production without prospective use, operational monitoring, and a release history. Missing evidence blocks promotion.

See the Research & Development Roadmap and Tool Catalog.